Neoplasm Metastasis  >>  oxaliplatin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT01399190: An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

Completed
N/A
68
Europe
Bevacizumab, Avastin®, Capecitabine, Xeloda®, Oxaliplatin, Eloxatin™
Hoffmann-La Roche
Colorectal Cancer
02/14
02/14
SIRFLOX, NCT00724503: FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Checkmark ASCO-GI 2016
Jan 2016 - Jan 2016: ASCO-GI 2016
Checkmark SIRFLOX
Nov 2015 - Nov 2015: SIRFLOX
Checkmark
More
Completed
N/A
530
US, Europe, RoW
SIR-Spheres yttrium-90 microspheres, mFOLFOX6m + SIRT, SIR-Spheres Y-90 microspheres, Systemic chemotherapy (FOLFOX), mFOLFOX6
Sirtex Medical
Colorectal Cancer, Colorectal Carcinoma, Liver Metastases
05/15
05/15

Download Options